Dr. Elias E. Loukas, MD

Dr. Loukas practices at Privia Medical Group of Georgia in Fayetteville, Georgia.

Dr. Loukas' NPI, 1003032574, was assigned on April 17, 2007. Dr. Loukas graduated from State University of New York Downstate Medical Center in 2005. Dr. Loukas holds Minnesota license 50685.

Dr. Loukas' primary practice is Privia Medical Group of Georgia, at 101 Yorktown Dr, Fayetteville, GA 30214 in Fayette County. The practice phone is (770) 460-4285.

Dr. Loukas' primary practice is Privia Medical Group of Georgia in Fayetteville, Georgia. Dr. Loukas is also affiliated with Dartmouth Hitchcock Medical Center. The medical group on file is Dartmouth Hitchcock Clinics Manchester. Dmand AI also links Dr. Loukas to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Loukas practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Loukas' primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Loukas is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Loukas' licenses on file in 3 states: Minnesota, New Hampshire and Rhode Island.

CMS data shows 149 Medicare services from Dr. Loukas across 3 procedure codes in 2024, for 64 Medicare patients. Medicare paid $10,980 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 64 Medicare patients who saw Dr. Loukas in 2024. The largest group is 65 to 74, with 23 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Loukas' median patient age at 63, with 44% women.

In 2024, Dr. Loukas wrote 30 Medicare Part D claims. 80% of them were for generic drugs. CMS names the drug for 23 of them, across 1 drug with 11 or more claims each, at $130 in total drug cost. In 2016, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Loukas for performance year 2024, reported through an alternative payment model (APM). Dr. Loukas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Loukas in 2022. Dr. Loukas' most frequent co-authors are Charles D. Brackett, MD, MPH and Colleen M. Kershaw, MD.

Dmand AI links Dr. Loukas to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

Dr. Loukas graduated from State University of New York Downstate Medical Center in 2005.